Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemoselective Covalent Modification of K-Ras(G12R) with a Small Molecule Electrophile
Ziyang Zhang, Johannes Morstein, Andrew K Ecker, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 35, pp. 15916-15921
Open Access | Times Cited: 91

Showing 26-50 of 91 citing articles:

Pitfalls and Considerations in Determining the Potency and Mutant Selectivity of Covalent Epidermal Growth Factor Receptor Inhibitors
Kristopher W. Hoyt, Daniel A. Urul, Blessing C. Ogboo, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 1, pp. 2-16
Open Access | Times Cited: 15
Technologies for Direct Detection of Covalent Protein–Drug Adducts
Elma Mons, Robbert Q. Kim, Monique P. C. Mulder
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 547-547
Open Access | Times Cited: 14
Facts and Hopes on RAS Inhibitors and Cancer Immunotherapy
Jesse Boumelha, Míriam Molina‐Arcas, Julian Downward
Clinical Cancer Research (2023) Vol. 29, Iss. 24, pp. 5012-5020
Open Access | Times Cited: 14
Design, Synthesis, and Bioevaluation of Pyrido[2,3-d]pyrimidin-7-ones as Potent SOS1 Inhibitors
Meiying Liu, Guizhen Zhou, Wenhong Su, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 2, pp. 183-190
Open Access | Times Cited: 13
Development of Receptor Desolvation Scoring and Covalent Sampling in DOCK 6: Methods Evaluated on a RAS Test Set
Yu-Hong Tan, Mayukh Chakrabarti, Reed M. Stein, et al.
Journal of Chemical Information and Modeling (2025)
Open Access
Targeted Covalent Modification Strategies for Drugging the Undruggable Targets
Tomonori Tamura, Masaharu Kawano, Itaru Hamachi
Chemical Reviews (2025)
Closed Access
Proteomic Ligandability Maps of Phosphorus(V) Stereoprobes Iden-tify Covalent TLCD1 Inhibitors
Hayden A. Sharma, Michael Bielecki, Meredith A. Holm, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Targeting KRASG13C: Exploring Warhead Orientation with Cyclic Linker-Based Inhibitors
Tonia Kirschner, J. M. Rodríguez, Emerson G. Moreira, et al.
Research Square (Research Square) (2025)
Closed Access
Reversible Small Molecule Multivariant Ras Inhibitors Display Tunable Affinity for the Active and Inactive Forms of Ras
Charles Parry, Francesca Pellicano, Alexander W. Schüttelkopf, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery
Kirsten McAulay, Alan Bilsland, Marta Bon
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1366-1366
Open Access | Times Cited: 22
Direct K-Ras Inhibitors to Treat Cancers: Progress, New Insights, and Approaches to Treat Resistance
Ruth Nussinov, Hyunbum Jang
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 231-253
Closed Access | Times Cited: 12
Tyrosine-targeted covalent inhibition of a tRNA synthetase aided by zinc ion
Hang Qiao, Mingyu Xia, Yiyuan Cheng, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 11
Selective type II TRK inhibitors overcome xDFG mutation mediated acquired resistance to the second-generation inhibitors selitrectinib and repotrectinib
Shuang Xiang, Xiaoyun Lu
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 2, pp. 517-532
Open Access | Times Cited: 11
From bench to bedside: current development and emerging trend of KRAS-targeted therapy
Yi Chen, Qiu-pei Liu, Hua Xie, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 4, pp. 686-703
Closed Access | Times Cited: 11
Natural products targeting RAS by multiple mechanisms and its therapeutic potential in cancer: An update since 2020
Yanqing Liu, Jie Chen, Xiang Li, et al.
Pharmacological Research (2025) Vol. 212, pp. 107577-107577
Open Access
Targeting RAS and associated proteins
Matthias Müller, Roger S. Goody, Daniel Rauh
Elsevier eBooks (2025)
Closed Access
Synthetic Approaches and Clinical Application of KRAS Inhibitors for Cancer Therapy
M. Jiang, Shaowei Ma, Ying Xuan, et al.
European Journal of Medicinal Chemistry (2025), pp. 117626-117626
Closed Access
Discovering and Targeting Dynamic Drugging Pockets of Oncogenic Proteins: The Role of Magnesium in Conformational Changes of the G12D Mutated Kirsten Rat Sarcoma-Guanosine Diphosphate Complex
Zheyao Hu, Jordi Martı́
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13865-13865
Open Access | Times Cited: 17
In silico drug derivatives for KRAS-G12D: free-energy surfaces in aqueous solution by well-tempered metadynamics simulations
Zheyao Hu, Jordi Martı́
Molecular Physics (2024)
Closed Access | Times Cited: 3
A Top-Down Proteomic Assay to Evaluate KRAS4B-Compound Engagement
Robert A. D’Ippolito, Dana Rabara, Maria Abreu Blanco, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 13, pp. 5223-5231
Open Access | Times Cited: 3
Structure-activity relationships of middle-size cyclic peptides, KRAS inhibitors derived from an mRNA display
Mirai Kage, Ryuji Hayashi, Atsushi Matsuo, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 110, pp. 117830-117830
Closed Access | Times Cited: 3
USP7 deubiquitinates KRAS and promotes non-small cell lung cancer
Bin Huang, Dan Cao, Xiao Yuan, et al.
Cell Reports (2024) Vol. 43, Iss. 11, pp. 114917-114917
Open Access | Times Cited: 3
Covalent Targeting of Histidine Residues with Aryl Fluorosulfates: Application to Mcl-1 BH3 Mimetics
Giulia Alboreggia, Parima Udompholkul, Emma L. Atienza, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 20214-20223
Open Access | Times Cited: 3
RAS signaling and immune cells: a sinister crosstalk in the tumor microenvironment
Yongting Liu, Bin Xie, Qiong Chen
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 8
Precision Oncology Comes of Age: Designing Best-in-Class Small Molecules by Integrating Two Decades of Advances in Chemistry, Target Biology, and Data Science
Darrin D. Stuart, Angel Guzman-Perez, Natasja Brooijmans, et al.
Cancer Discovery (2023) Vol. 13, Iss. 10, pp. 2131-2149
Open Access | Times Cited: 8

Scroll to top